A straightforward estimation of cardiac substructure exposure for clinical practice: example of breast rotational intensity modulated radiation therapy
Streszczenie
Introduction. Mean heart dose (MHD) is the most widely used dosimetric parameter for cardiac sparing during treatment planning. Specific cardiac substructure exposure could be more clinically important, but MHD cannot provide the radiation oncologist with precise insight at the substructural level.
Materials. We propose a straightforward method for estimating cardiac substructure exposure based on linear regressions between mean dose delivered to cardiac substructures and MHD. We focused on breast irradiation with intensity modulated radiation therapy as an application example. Correlations between mean dose to cardiac substructures and MHD were statistically significant and usually moderate (r > 0.5) or strong (r > 0.7), allowing the use of such linear regression models to estimate cardiac substructure exposure from MHD for clinical practice.
Conclusion. This method can be extrapolated to other clinical situations for daily practice, albeit with some restrictions.
Słowa kluczowe: cardiac substructure exposurecardiotoxicityintensity modulated radiation therapybreast cancer
Referencje
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. The Lancet. 2014; 383(9935): 2127–2135.
- Lauche O, Kirova YM, Fenoglietto P, et al. Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy. World J Radiol. 2016; 8(8): 735–742.
- Duane F, Aznar MC, Bartlett F, et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol. 2017; 122(3): 416–422.
- Piroth MD, Baumann R, Budach W, et al. Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention. Strahlenther Onkol. 2019; 195(1): 1–12.
- Stam B, Peulen H, Guckenberger M, et al. Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients. Radiother Oncol. 2017; 123(3): 370–375.
- Reshko LB, Kalman NS, Hugo GD, et al. Cardiac radiation dose distribution, cardiac events and mortality in early-stage lung cancer treated with stereotactic body radiation therapy (SBRT). J Thorac Dis. 2018; 10(4): 2346–2356.
